Trade

Follow Our Latest COVID-19 Updates

SINGAPORE: Guide on COVID-19 Vaccination: Regulatory Issue

COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread across the globe causing severe economic and social disruption worldwide. While the world continues to see the detrimental effects of COVID-19, it also begins to welcome the unfolding global endeavour of vaccine development and deployment. The global pharmaceutical industry has announced its commitment towards developing vaccines for COVID-19, and several vaccines have since been authorised by various national regulatory authorities for public use, with vaccinations taking place in several countries across Southeast Asia.

This quick guide explores the various regulatory issues arising in different parts of Southeast Asia, briefly covering vaccine registration and administration, as well as each country's regulatory framework, as of 20 April 2021.

SINGAPORE: Joint Ministerial Statement on Ensuring Supply Chain Connectivity amidst COVID-19 Situation

On 7 April 2020, a Joint Ministerial Statement was issued by Singapore, Australia, Brunei Darussalam, Canada, Chile, Lao PDR, Myanmar, New Zealand and Uruguay regarding their collective response to combat COVID-19 and its repercussions on trade disruptions. In this Update, we highlight the commitments by the countries to maintaining open and connected supply chains, and to working closely to identify and address trade disruptions with ramifications on the flow of necessities.